drugset
drugset / Trial / NCT05602090

Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials

NCT05602090 ↗

Phase 2/3 Unknown 120 enrolled Beni-Suef University
RandomizedParallel-groupOpen-labelTreatment

Summary

Effect of Growth Hormone Adjuvant Therapy on ICSI Trials For Poor ovarian Reserve Patients

Timeline

Start
2022-02-01
Primary completion
2023-09-04
Completion
2023-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 4 iu Subcutaneous

Indications

ovarian dysfunction